1 / 40

Magnesium and the Risk for Type 2 Diabetes Mellitus

Risk Assessment Group Seminar. Magnesium and the Risk for Type 2 Diabetes Mellitus. 李妮臻 2004/08/03. INTRODUCTION. Type 2 Diabetes Mellitus. Definition Hyperglycemia resulted from insulin resistance with an insulin secretory defect Excess risk for: Blindness Renal failure

raja
Download Presentation

Magnesium and the Risk for Type 2 Diabetes Mellitus

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Risk Assessment Group Seminar Magnesium and the Risk for Type 2 Diabetes Mellitus 李妮臻 2004/08/03

  2. INTRODUCTION

  3. Type 2 Diabetes Mellitus Definition • Hyperglycemia resulted from insulin resistance with an insulin secretory defect Excess risk for: • Blindness • Renal failure • Cardiovascular disease

  4. Hypomagnesemia in diabetes Intracellular magnesium • Cofactor for enzymes in glucose metabolism • Maintain tyrosine kinase activity at insulin receptor Insulin as a regulatory hormone • Stimulate magnesium uptake by cell • Insulin receptor-mediated process

  5. Hypothesis

  6. Magnesium status in pathogenesis of diabetes • Serum magnesium • Dietary intake of magnesium

  7. Reference 1:Serum and Dietary Magnesium and the Risk for Type 2 Diabetes Mellitus The Atherosclerosis Risk in Communities Study Arch Intern Med. 1999;159:2151-2159

  8. PARTICIPANTS AND METHODS

  9. The Atherosclerosis Risk in Communities Study Study design • Prospective study • 6 years of follow-up (2 visits) • Etiology of atherosclerosis and its clinical sequelae Participants • Aged 45-64 years • Four US communities: --- Forsyth County, North Carolina --- Jackson, Mississippi --- Suburbs of Minneapolis, Minnesota --- Washington County, Maryland

  10. Participants Exclude: • Ethnicity other than black or white • Had diabetes at baseline • Missing exposure or outcome information • Nonfasting (< 8 hours) • Unavailable for follow-up • Dead 10871 participants

  11. Exposure assessment Blood collection • Fasting ≧ 12 hrs • Serum magnesium, glucose level, insulin level, calcium level, potassium level Dietary intake • 61-item food frequency questionnaire (FFQ) • Mg intake: milligrams/4.2 kJ daily energy intake • Lack of validity study for magnesium

  12. Outcome assessment Diabetes mellitus definition: • Fasting glucose level ≧ 126 mg/dL • Non-fasting glucose level ≧ 200 mg/dL • Current use of diabetic medication • Doctor ever told that he/she had diabetes Met any of these conditions at visit 2 or visit 3 →incident cases of diabetes

  13. Statistical analysis Stratified by race Serum Mg level • Categorized into 6 groups • Highest level: ≧0.95 mmol/L (Reference group) Dietary Mg intake • Categorize into quartiles • Highest quartile as reference group

  14. Statistical analysis (cont.) Statistical significance • Analysis of variance • χ2analysis Association between Mg and diabetes • Logistic regression model • Odds ratio

  15. RESULT

  16. Baseline characteristics (Black)

  17. Baseline characteristics (White)

  18. Incidence of type 2 diabetes

  19. Serum Mg and risk for type 2 diabetes

  20. Comparison of cross-sectional and prospective association Cross-sectional Prospective

  21. Dietary Mg Intake

  22. CONCLUSIONS

  23. Three main conclusions • Inverse relationship between serum Mg level and development of type 2 diabetes ---White middle-aged adults. • Cross-sectional relationship ---Effect of diabetes on serum Mg level • No association between dietary Mg intake and incident type 2 diabetes.

  24. Reference 2: Dietary Magnesium Intake in Relation to Plasma Insulin Levels and Risk of Type 2 Diabetes in Women Diabetes Care 27:59-65,2004

  25. RESEARCH DESIGN AND METHODS

  26. Women’s Health Study (WHS) Study design • Randomized, double-blind, placebo controlled trial • Low-dose aspirin and vitamin E • Primary prevention of cardiovascular disease and cancer Participants • Aged ≧ 45 years • 39876 female health professionals • Free of coronary heart disease, stroke, and cancer.

  27. Assessment of Mg intake • 131-item SFFQ • Commonly used unit or portion size • 9 possible responses: never ~ 6 or more times per day • Good validity for magnesium SFFQ vs. 2 weeks of diet records r = 0.76

  28. Ascertainment of incident type 2 diabetes Ask annually about type 2 diabetes diagnosis ↓ Questionnaire: • Onset of disease • Symptoms • Diagnostic tests • Hypoglycemic treatment ↓ Confirm type 2 diabetes: • Guidelines of the American Diabetes Association

  29. Assessment of fasting insulin levels • 349 randomly selected health women (Serve as control in WHS) • Double antibody systems --- < 0.2 % cross-reactivity between insulin and its precursors

  30. Data analysis • Magnesium intake --- Categorized into quintiles --- Lowest quintile as reference • Cox proportional hazard model → rate ratio • Stratified analyses by BMI (< or ≧ 25 kg/m2)

  31. Data analysis (cont.) Cross-sectional analysis • Natural logarithm of insulin level • Multiple linear regression models • Modifying effect of BMI --- Stratified by BMI

  32. RESULTS

  33. Baseline characteristics

  34. RRs of type 2 diabetes

  35. RRs stratified by BMI

  36. Plasma fasting insulin level

  37. Fasting insulin level in two BMI categories BMI ≧ 25

  38. CONCLUSIONS

  39. For middle-aged women risk of type 2 diabetes Magnesium intake plasma insulin level • Inverse association • Significant among overweight (≧ 25 kg/m2) --- Highest quintile had a 22% lower risk • Beneficial effects --- Greater among overweight people --- Who are prone to insulin resistance.

  40. THANKS FOR YOUR ATTENTION!

More Related